Diabetes, Vol 46, Issue 11 1678-1683, Copyright © 1997 by American Diabetes Association

ARTICLES

TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone

PD Miles, OM Romeo, K Higo, A Cohen, K Rafaat and JM Olefsky
Department of Surgery, University of California, San Diego 92103, USA. pmiles@ucsd.edu

Tumor necrosis factor (TNF)-alpha may play a role in the insulin resistance of obesity and NIDDM. Troglitazone is a new orally active hypoglycemic agent that has been shown to ameliorate insulin resistance and hyperinsulinemia in both diabetic animal models and NIDDM subjects. To determine whether this drug could prevent the development of TNF-alpha-induced insulin resistance, glucose turnover was assessed in rats infused with cytokine and pretreated with troglitazone. Normal male Sprague-Dawley rats were fed normal powdered food with or without troglitazone as a food admixture (0.2%). After approximately 10 days, rats were infused with TNF-alpha for 4-5 days, producing a plasma concentration of 632 +/- 30 pg/ml. In vivo insulin action was measured by the euglycemic-hyperinsulinemic clamp technique at a submaximal (24 micromol x kg[-1] x min[-1]) and maximal insulin infusion rate (240 micromol x kg[-1] x min[-1]). TNF-alpha infusion resulted in a pronounced reduction in submaximal insulin-stimulated glucose disposal rate (GDR) (97 +/- 10 vs. 141 +/- 4 micromol x kg[-1] x min[-1], P < 0.05), maximal GDR (175 +/- 8 vs. 267 +/- 6 micromol x kg[-1] x min[-1], P < 0.01), and in insulin receptor-tyrosine kinase activity (IR-TKA) (248 +/- 39 vs. 406 +/- 32 fmol ATP/fmol IR, P < 0.05). It also led to a marked increase in basal insulin (90 +/- 24 vs. 48 +/- 6 micromol/l, P < 0.05) and free fatty acid (FFA) concentration (2.56 +/- 0.76 vs. 0.87 +/- 0.13 mmol/l, P < 0.01). Troglitazone treatment completely prevented the TNF-alpha-induced decline in submaximal GDR (133 +/- 16 vs. 141 +/- 4 micromol x kg[-1] x min[-1], NS) and maximal GDR (271 +/- 19 vs. 267 +/- 6 micromol x kg[-1] x min[-1], NS). The hyperlipidemia was partially corrected by troglitazone (1.53 +/- 0.28 vs. 0.87 +/- 0.13 mmol/l, P < 0.05), while IR-TKA and insulin concentration remained unaffected by the drug. Troglitazone restores insulin action possibly by lowering the FFA concentration of the blood and/or by stimulating glucose uptake at an intracellular point distal to insulin receptor autophosphorylation in muscle. If TNF-alpha plays a role in the development of the obesity/NIDDM syndrome, troglitazone may prove useful in its treatment.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				B. K. Pedersen and M. A. Febbraio Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6 Physiol Rev, October 1, 2008; 88(4): 1379 - 1406. [Abstract] [Full Text] [PDF]

				P. Dallaire, K. Bellmann, M. Laplante, S. Gelinas, C. Centeno-Baez, P. Penfornis, M.-L. Peyot, M. G. Latour, J. Lamontagne, M. E. Trujillo, et al. Obese Mice Lacking Inducible Nitric Oxide Synthase Are Sensitized to the Metabolic Actions of Peroxisome Proliferator-Activated Receptor-{gamma} Agonism Diabetes, August 1, 2008; 57(8): 1999 - 2011. [Abstract] [Full Text] [PDF]

				H. Liang, B. Yin, H. Zhang, S. Zhang, Q. Zeng, J. Wang, X. Jiang, L. Yuan, C.-Y. Wang, and Z. Li Blockade of Tumor Necrosis Factor (TNF) Receptor Type 1-Mediated TNF-{alpha} Signaling Protected Wistar Rats from Diet-Induced Obesity and Insulin Resistance Endocrinology, June 1, 2008; 149(6): 2943 - 2951. [Abstract] [Full Text] [PDF]

				Y. Kawamata, T. Imamura, J. L. Babendure, J.-C. Lu, T. Yoshizaki, and J. M. Olefsky Tumor Necrosis Factor Receptor-1 Can Function through a G{alpha}q/11-beta-Arrestin-1 Signaling Complex J. Biol. Chem., September 28, 2007; 282(39): 28549 - 28556. [Abstract] [Full Text] [PDF]

				W. Liao, M. T. A. Nguyen, T. Yoshizaki, S. Favelyukis, D. Patsouris, T. Imamura, I. M. Verma, and J. M. Olefsky Suppression of PPAR-{gamma} attenuates insulin-stimulated glucose uptake by affecting both GLUT1 and GLUT4 in 3T3-L1 adipocytes Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E219 - E227. [Abstract] [Full Text] [PDF]

				J. Diaz-Delfin, M. Morales, and C. Caelles Hypoglycemic Action of Thiazolidinediones/Peroxisome Proliferator-Activated Receptor {gamma} by Inhibition of the c-Jun NH2-Terminal Kinase Pathway Diabetes, July 1, 2007; 56(7): 1865 - 1871. [Abstract] [Full Text] [PDF]

				D. Aronson, H. Hammerman, M. R. Kapeliovich, A. Suleiman, Y. Agmon, R. Beyar, W. Markiewicz, and M. Suleiman Fasting Glucose in Acute Myocardial Infarction: Incremental value for long-term mortality and relationship with left ventricular systolic function Diabetes Care, April 1, 2007; 30(4): 960 - 966. [Abstract] [Full Text] [PDF]

				B. A. Bhatt, J. J. Dube, N. Dedousis, J. A. Reider, and R. M. O'Doherty Diet-induced obesity and acute hyperlipidemia reduce I{kappa}B{alpha} levels in rat skeletal muscle in a fiber-type dependent manner Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R233 - R240. [Abstract] [Full Text] [PDF]

				M. D. Robertson, A. S. T. Bickerton, A. L. Dennis, H. Vidal, D. P. Jewell, and K. N. Frayn Enhanced Metabolic Cycling in Subjects after Colonic Resection for Ulcerative Colitis J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2747 - 2754. [Abstract] [Full Text] [PDF]

				B. R. Gedulin, S. E. Nikoulina, P. A. Smith, G. Gedulin, L. L. Nielsen, A. D. Baron, D. G. Parkes, and A. A. Young Exenatide (Exendin-4) Improves Insulin Sensitivity and {beta}-Cell Mass in Insulin-Resistant Obese fa/fa Zucker Rats Independent of Glycemia and Body Weight Endocrinology, April 1, 2005; 146(4): 2069 - 2076. [Abstract] [Full Text] [PDF]

				Q. Shen, G. W. Cline, G. I. Shulman, M. D. Leibowitz, and P. J. A. Davies Effects of Rexinoids on Glucose Transport and Insulin-mediated Signaling in Skeletal Muscles of Diabetic (db/db) Mice J. Biol. Chem., May 7, 2004; 279(19): 19721 - 19731. [Abstract] [Full Text] [PDF]

				K. E. Wellen, K. T. Uysal, S. Wiesbrock, Q. Yang, H. Chen, and G. S. Hotamisligil Interaction of Tumor Necrosis Factor-{alpha}- and Thiazolidinedione-Regulated Pathways in Obesity Endocrinology, May 1, 2004; 145(5): 2214 - 2220. [Abstract] [Full Text] [PDF]

				A. G. Pittas, N. A. Joseph, and A. S. Greenberg Adipocytokines and Insulin Resistance J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 447 - 452. [Full Text] [PDF]

				T. Radaelli, A. Varastehpour, P. Catalano, and S. Hauguel-de Mouzon Gestational Diabetes Induces Placental Genes for Chronic Stress and Inflammatory Pathways Diabetes, December 1, 2003; 52(12): 2951 - 2958. [Abstract] [Full Text] [PDF]

				R.T. Jagoe and M.P.K.J. Engelen Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease Eur. Respir. J., November 2, 2003; 22(46_suppl): 52s - 63s. [Abstract] [Full Text] [PDF]

				H. Ruan, H. J. Pownall, and H. F. Lodish Troglitazone Antagonizes Tumor Necrosis Factor-{alpha}-induced Reprogramming of Adipocyte Gene Expression by Inhibiting the Transcriptional Regulatory Functions of NF-{kappa}B J. Biol. Chem., July 18, 2003; 278(30): 28181 - 28192. [Abstract] [Full Text] [PDF]

				A. Kubaszek, J. Pihlajamaki, V. Komarovski, V. Lindi, J. Lindstrom, J. Eriksson, T. T. Valle, H. Hamalainen, P. Ilanne-Parikka, S. Keinanen-Kiukaanniemi, et al. Promoter Polymorphisms of the TNF-{alpha} (G-308A) and IL-6 (C-174G) Genes Predict the Conversion From Impaired Glucose Tolerance to Type 2 Diabetes: The Finnish Diabetes Prevention Study Diabetes, July 1, 2003; 52(7): 1872 - 1876. [Abstract] [Full Text] [PDF]

				C.-H. Lee, P. Olson, and R. M. Evans Minireview: Lipid Metabolism, Metabolic Diseases, and Peroxisome Proliferator-Activated Receptors Endocrinology, June 1, 2003; 144(6): 2201 - 2207. [Abstract] [Full Text] [PDF]

				V. R. Aroda and R. R. Henry Thiazolidinediones: Potential Link Between Insulin Resistance and Cardiovascular Disease Diabetes Spectr, April 1, 2003; 16(2): 120 - 125. [Abstract] [Full Text] [PDF]

				H. Ruan, P. D. G. Miles, C. M. Ladd, K. Ross, T. R. Golub, J. M. Olefsky, and H. F. Lodish Profiling Gene Transcription In Vivo Reveals Adipose Tissue as an Immediate Target of Tumor Necrosis Factor-{alpha}: Implications for Insulin Resistance Diabetes, November 1, 2002; 51(11): 3176 - 3188. [Abstract] [Full Text] [PDF]

				N. Shojima, H. Sakoda, T. Ogihara, M. Fujishiro, H. Katagiri, M. Anai, Y. Onishi, H. Ono, K. Inukai, M. Abe, et al. Humoral Regulation of Resistin Expression in 3T3-L1 and Mouse Adipose Cells Diabetes, June 1, 2002; 51(6): 1737 - 1744. [Abstract] [Full Text] [PDF]

				H. Ruan, N. Hacohen, T. R. Golub, L. Van Parijs, and H. F. Lodish Tumor Necrosis Factor-{alpha} Suppresses Adipocyte-Specific Genes and Activates Expression of Preadipocyte Genes in 3T3-L1 Adipocytes: Nuclear Factor-{kappa}B Activation by TNF-{alpha} Is Obligatory Diabetes, May 1, 2002; 51(5): 1319 - 1336. [Abstract] [Full Text] [PDF]

				H. Taegtmeyer, P. McNulty, and M. E. Young Adaptation and Maladaptation of the Heart in Diabetes: Part I: General Concepts Circulation, April 9, 2002; 105(14): 1727 - 1733. [Full Text] [PDF]

				A. L. Hevener, D. Reichart, A. Janez, and J. Olefsky Thiazolidinedione Treatment Prevents Free Fatty Acid-Induced Insulin Resistance in Male Wistar Rats Diabetes, October 1, 2001; 50(10): 2316 - 2322. [Abstract] [Full Text]

				H. F. Escobar-Morreale, R. M. Calvo, J. Sancho, and J. L. San Millan TNF-{alpha} and Hyperandrogenism: A Clinical, Biochemical, and Molecular Genetic Study J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3761 - 3767. [Abstract] [Full Text] [PDF]

				M. Iwata, T. Haruta, I. Usui, Y. Takata, A. Takano, T. Uno, J. Kawahara, E. Ueno, T. Sasaoka, O. Ishibashi, et al. Pioglitazone Ameliorates Tumor Necrosis Factor-{alpha}-Induced Insulin Resistance by a Mechanism Independent of Adipogenic Activity of Peroxisome Proliferator-Activated Receptor-{gamma} Diabetes, May 1, 2001; 50(5): 1083 - 1092. [Abstract] [Full Text]

				S. J. Pan, J. Hancock, Z. Ding, D. Fogt, M. Lee, and J. L. Ivy Effects of clenbuterol on insulin resistance in conscious obese Zucker rats Am J Physiol Endocrinol Metab, April 1, 2001; 280(4): E554 - E561. [Abstract] [Full Text] [PDF]

				K. Hida, J. Wada, H. Zhang, K. Hiragushi, Y. Tsuchiyama, K. Shikata, and H. Makino Identification of genes specifically expressed in the accumulated visceral adipose tissue of OLETF rats J. Lipid Res., October 1, 2000; 41(10): 1615 - 1622. [Abstract] [Full Text]

				R. Mukherjee, P. A. Hoener, L. Jow, J. Bilakovics, K. Klausing, D. E. Mais, A. Faulkner, G. E. Croston, and J. R. Paterniti Jr. A Selective Peroxisome Proliferator-Activated Receptor-{gamma} (PPAR{gamma}) Modulator Blocks Adipocyte Differentiation but Stimulates Glucose Uptake in 3T3-L1 Adipocytes Mol. Endocrinol., September 1, 2000; 14(9): 1425 - 1433. [Abstract] [Full Text]

				T. Rönnemaa, K. Pulkki, and J. Kaprio Serum Soluble Tumor Necrosis Factor-{alpha} Receptor 2 Is Elevated in Obesity But Is Not Related to Insulin Sensitivity: A Study in Identical Twins Discordant for Obesity J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2728 - 2732. [Abstract] [Full Text]

				H. Xu, J. K. Sethi, and G. S. Hotamisligil Transmembrane Tumor Necrosis Factor (TNF)-alpha Inhibits Adipocyte Differentiation by Selectively Activating TNF Receptor 1 J. Biol. Chem., September 10, 1999; 274(37): 26287 - 26295. [Abstract] [Full Text] [PDF]

				L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice The Insulin-Related Ovarian Regulatory System in Health and Disease Endocr. Rev., August 1, 1999; 20(4): 535 - 582. [Abstract] [Full Text] [PDF]

				G. Kwon, G. Xu, C. A. Marshall, and M. L. McDaniel Tumor Necrosis Factor alpha -induced Pancreatic beta -Cell Insulin Resistance Is Mediated by Nitric Oxide and Prevented by 15-Deoxy-Delta 12,14-prostaglandin J2 and Aminoguanidine. A ROLE FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR gamma  ACTIVATION AND iNOS EXPRESSION J. Biol. Chem., June 25, 1999; 274(26): 18702 - 18708. [Abstract] [Full Text] [PDF]

				S. Khanna, S. Roy, L. Packer, and C. K. Sen Cytokine-induced glucose uptake in skeletal muscle: redox regulation and the role of alpha -lipoic acid Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1999; 276(5): R1327 - R1333. [Abstract] [Full Text] [PDF]

				T. P. Ciaraldi, L. Carter, S. Mudaliar, P. A. Kern, and R. R. Henry Effects of Tumor Necrosis Factor-{alpha} on Glucose Metabolism in Cultured Human Muscle Cells from Nondiabetic and Type 2 Diabetic Subjects Endocrinology, December 1, 1998; 139(12): 4793 - 4800. [Abstract] [Full Text] [PDF]

				C. L. Morin, E. C. Gayles, D. A. Podolin, Y. Wei, M. Xu, and M. J. Pagliassotti Adipose Tissue-Derived Tumor Necrosis Factor Activity Correlates with Fat Cell Size But Not Insulin Action in Aging Rats Endocrinology, December 1, 1998; 139(12): 4998 - 5005. [Abstract] [Full Text] [PDF]

				S. C. Souza, L. M. de Vargas, M. T. Yamamoto, P. Lien, M. D. Franciosa, L. G. Moss, and A. S. Greenberg Overexpression of Perilipin A and B Blocks the Ability of Tumor Necrosis Factor alpha  to Increase Lipolysis in 3T3-L1 Adipocytes J. Biol. Chem., September 18, 1998; 273(38): 24665 - 24669. [Abstract] [Full Text] [PDF]

				G. Paolisso, M. R. Rizzo, G. Mazziotti, M. R. Tagliamonte, A. Gambardella, M. Rotondi, C. Carella, D. Giugliano, M. Varricchio, and F. D'Onofrio Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha Am J Physiol Endocrinol Metab, August 1, 1998; 275(2): E294 - E299. [Abstract] [Full Text] [PDF]

				D. J. Gross, L. Weiss, I. Reibstein, J. van den Brand, H. Okamoto, A. Clark, and S. Slavin Amelioration of Diabetes in Nonobese Diabetic Mice with Advanced Disease by Linomide-Induced Immunoregulation Combined with Reg Protein Treatment Endocrinology, May 1, 1998; 139(5): 2369 - 2374. [Abstract] [Full Text] [PDF]

				M. Ryden, A. Dicker, V. van Harmelen, H. Hauner, M. Brunnberg, L. Perbeck, F. Lonnqvist, and P. Arner Mapping of Early Signaling Events in Tumor Necrosis Factor-alpha -mediated Lipolysis in Human Fat Cells J. Biol. Chem., January 4, 2002; 277(2): 1085 - 1091. [Abstract] [Full Text] [PDF]

				M. Guerre-Millo, P. Gervois, E. Raspe, L. Madsen, P. Poulain, B. Derudas, J.-M. Herbert, D. A. Winegar, T. M. Willson, J.-C. Fruchart, et al. Peroxisome Proliferator-activated Receptor alpha Activators Improve Insulin Sensitivity and Reduce Adiposity J. Biol. Chem., May 26, 2000; 275(22): 16638 - 16642. [Abstract] [Full Text] [PDF]